National Lab Briefs

W.Va. To NSF: Give Us The Telescope NSF’s idea to turn an astronomical disaster into a bonanza for astrophysicists has run into opposition from two influential West Virginia Democrats. NSF officials knew that Sen. Robert Byrd, chairman of the Senate Appropriations Committee that passes judgment on NSF’s budget, and Sen. Jay Rockefeller, who sits on the Senate Commerce and Science Committee that authorizes its programs, were eager for the state to recover from the unexpected collaps

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

NSF’s idea to turn an astronomical disaster into a bonanza for astrophysicists has run into opposition from two influential West Virginia Democrats. NSF officials knew that Sen. Robert Byrd, chairman of the Senate Appropriations Committee that passes judgment on NSF’s budget, and Sen. Jay Rockefeller, who sits on the Senate Commerce and Science Committee that authorizes its programs, were eager for the state to recover from the unexpected collapse last November of the federally funded 300-meter radio telescope at Green Bank, W. Va. And they thought they had the perfect solution: a planned $120 million gravity wave detector that NSF believes has a higher scientific priority than a replacement telescope. But Byrd and Rockefeller have decided after a meeting with NSF officials that a new telescope, not a gravity wave detector, “offers—the best promise for jobs, education, tourism, and scientific prestige” for their state. Their stance creates a dilemma for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies